3212 The Immune Response Against Respiratory Pathogens in Patients with Chronic Rhinosinusitis/Nasal Polyps and Asthma with or without Sensitivity to Aspirin

Tuesday, 6 December 2011: 13:15 - 13:30
Costa Maya 1 (Cancún Center)

Agnieszka Olszewska-Ziąber, MD, PhD , Department of Immunology, Rheumatology and Allergy, Medical University of Lodz, Łódź 91-360, Poland

Marzanna Jarzębska , Department of Immunology, Rheumatology and Allergy, Medical University of Łódź, Łódź, Poland

Marek L Kowalski, MD, PhD, Professor , Department of Immunology, Rheumatology and Allergy, Medical University of Lodz, Lodz, Poland

Background: Viral and bacterial infections can modulate the ongoing inflammation in both upper and lower airways  of patients with  chronic rhinosinusitis  with nasal polyps ( CRS/NP) and asthma. It not clear  if the protective  immune response to pathogens may differ depending on the disease severity.  

Aim:  To compare serum  IgG  immune response against respiratory pathogens in patients  with  chronic  airway disease( CRS/NP and   asthma)   with  and without   sensitivity to aspirin ,and to refer the sensitization  to  severity   of  chronic rhinosinusitis

 Methods:  We  recruited 73 patients with  CRS/NP and asthma  with ( 43 patients)  and without  ( 30 patients )  hypersensitivity to aspirin .  The extent of mucosal  hypertrophy  in paranasal sinuses  was assessed by  CT scans and  the  sense of smell  was valuated  with  “sniffing smell” test . Serum IgG immunoglobulin  levels against respiratory  pathogens  : Respiratory Syncytial  Virus (RSV), Adenowirus (ADV) , Parainfluenza virus ( PIV) and Mycoplasma pneumoniae  were determined by ELISA .

Results:

Patients with ASA-hypersensitivity  had history of significantly more  nasal polypectomies (p=0.002) , lower smell  test score (p=0.03) and   higher mean  paranasal  CT score ( p =0.03) as compared to ASA-tolerant patients, reflecting higher severity of the upper airway disease. The percentage of positive serological testing  to  respiratory pathogens was very high   in the whole group of patients with CRS/NP and asthma ( RSV -95.8% ; ADV-  95.9%,  PIV- 84.9%  and Mycoplasma pneumonieae-   100% patients ) without any difference between ASA-sensitive and ASA-tolerant subjects.  Patients with ASA-sensitivity had significantly  lower concentrations of PIV- specific IgG  ( mean  188.67±34.46  U/ml versus  207.56±30.036 U/ml    ; p<0,04) as compared to ASA-tolerant subjects .   There was  a significant trend ( p<0,048  ) for lower  PIV –specific  IgG concentrations with increased number of polypectomies . No  correlation of IgG immunoglobulin concentrations for other pathogens   with  the number of polypectomies,   paranasal sinuses  CT score or presence of smell were observed . 

Conclusions: Patients with CRS/NP and asthma had high frequency of  IgG immunoglobulin against common respiratory pathogens .  Serum IgG  immune response to paramyxoviruses  may  be  related to  the  recurrence of  nasal polyps  and  the presence of  aspirin sensitivity .